United States · FDA National Drug Code directory

Lotensin HCT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
30698-453_4b9222f7-7b31-4781-e063-6394a90ab188
Product NDC
30698-453
Form
TABLET
Composition / generic term
benazepril hydrochloride and hydrochlorothiazide
Labeler
Validus Pharmaceuticals LLC
Marketing category
NDA
Marketing start / end (source format)
19920530
Source listing expiry
20271231

Source-listed ingredients

  • BENAZEPRIL HYDROCHLORIDE — 20 mg/1
  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (30698-453-01) · 30698-453-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →